Janet Fauls has been named vice president of regulatory affairs and quality assurance for CardioGenesis (Foothill Ranch, California). Fauls formerly was the director of worldwide regulatory affairs for Allergan. CardioGenesis develops systems using lasers for transmyocardial revascularization and percutaneous myocardial revascularization.
H. Clark Adams has been named executive vice president of sales, marketing and business development for Data Sciences International (St. Paul, Minnesota). Most recently, Adams served as president of Entrepreneurial Management and Consulting Services. Data Sciences is a developer of wireless implantable physiologic monitors, and Adams will oversee the launch of a new DSI device, now in development, designed to aid in the treatment of congestive heart failure by monitoring left ventricular pressure in an outpatient setting.
Michael Henson said in mid-December that he would step down as board chairman of Radiance Medical (Irvine, California), effective Jan. 1. Henson is a founder of both Radiance and its predecessor company, Cardiovascular Dynamics, and served as CEO of the combined companies until January 2001. He will continue to serve as a member of the board of directors. Jeffrey O'Donnell, former president and CEO of Radiance, replaces Henson as chairman. Radiance develops radiation delivery catheters for use in the coronary and vascular systems to prevent restenosis following interventional treatment of atherosclerosis.
Dennis Wallach, head of the Spine Group subsidiary of Sulzer Medica (Winterthur, Switzerland), has been named to head the company's Cardiovascular Prostheses Division. Wallach replaces Terry Marlatt, who will leave the company after 14 years of service.